Literature DB >> 34610981

Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.

Ruifang Li-Gao1, David A Hughes2,3, Jan B van Klinken4, Renée de Mutsert5, Frits R Rosendaal5, Dennis O Mook-Kanamori5,6, Nicholas J Timpson2,3, Ko Willems van Dijk4,7,8.   

Abstract

Humans spend the greater part of the day in a postprandial state. However, the genetic basis of postprandial blood measures is relatively uncharted territory. We examined the genetics of variation in concentrations of postprandial metabolites (t = 150 min) in response to a liquid mixed meal through genome-wide association studies (GWAS) performed in the Netherlands Epidemiology of Obesity (NEO) study (n = 5,705). The metabolite response GWAS identified an association between glucose change and rs10830963:G in the melatonin receptor 1B (β [SE] -0.23 [0.03], P = 2.15 × 10-19). In addition, the ANKRD55 locus led by rs458741:C showed strong associations with extremely large VLDL (XXLVLDL) particle response (XXLVLDL total cholesterol: β [SE] 0.17 [0.03], P = 5.76 × 10-10; XXLVLDL cholesterol ester: β [SE] 0.17 [0.03], P = 9.74 × 10-10), which also revealed strong associations with body composition and diabetes in the UK Biobank (P < 5 × 10-8). Furthermore, the associations between XXLVLDL response and insulinogenic index, HOMA-β, Matsuda insulin sensitivity index, and HbA1c in the NEO study implied the role of chylomicron synthesis in diabetes (with false discovery rate-corrected q <0.05). To conclude, genetic studies of metabolomics change after a liquid meal illuminate novel pathways for glucose and lipid metabolism. Further studies are warranted to corroborate biological pathways of the ANKRD55 locus underlying diabetes.
© 2021 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34610981     DOI: 10.2337/db21-0397

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  6 in total

Review 1.  Metabolomics of Type 1 and Type 2 Diabetes: Insights into Risk Prediction and Mechanisms.

Authors:  Daniel Gonzalez Izundegui; Matthew Nayor
Journal:  Curr Diab Rep       Date:  2022-02-03       Impact factor: 4.810

Review 2.  Genetics of Type 2 Diabetes: Implications from Large-Scale Studies.

Authors:  Natalie DeForest; Amit R Majithia
Journal:  Curr Diab Rep       Date:  2022-03-19       Impact factor: 5.430

Review 3.  Spotlight on very-low-density lipoprotein as a driver of cardiometabolic disorders: Implications for disease progression and mechanistic insights.

Authors:  Hsiang-Chun Lee; Alexander Akhmedov; Chu-Huang Chen
Journal:  Front Cardiovasc Med       Date:  2022-10-04

4.  Response of circulating metabolites to an oral glucose challenge and risk of cardiovascular disease and mortality in the community.

Authors:  Daniel Gonzalez Izundegui; Patricia E Miller; Ravi V Shah; Clary B Clish; Maura E Walker; Gary F Mitchell; Robert E Gerszten; Martin G Larson; Ramachandran S Vasan; Matthew Nayor
Journal:  Cardiovasc Diabetol       Date:  2022-10-15       Impact factor: 8.949

5.  Identification of Novel Genes Involved in Hyperglycemia in Mice.

Authors:  Wenke Jonas; Oliver Kluth; Anett Helms; Sarah Voß; Markus Jähnert; Pascal Gottmann; Thilo Speckmann; Birgit Knebel; Alexandra Chadt; Hadi Al-Hasani; Annette Schürmann; Heike Vogel
Journal:  Int J Mol Sci       Date:  2022-03-16       Impact factor: 5.923

Review 6.  Investigating the Postprandial Metabolome after Challenge Tests to Assess Metabolic Flexibility and Dysregulations Associated with Cardiometabolic Diseases.

Authors:  Gaïa Lépine; Marie Tremblay-Franco; Sabrine Bouder; Laurianne Dimina; Hélène Fouillet; François Mariotti; Sergio Polakof
Journal:  Nutrients       Date:  2022-01-21       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.